{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-09-25",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "product_ndc": "60687-808",
      "generic_name": "Darunavir",
      "labeler_name": "American Health Packaging",
      "brand_name": "Darunavir",
      "active_ingredients": [
        {
          "name": "DARUNAVIR DIHYDRATE",
          "strength": "600 mg/1"
        }
      ],
      "finished": true,
      "packaging": [
        {
          "package_ndc": "60687-808-21",
          "description": "30 BLISTER PACK in 1 CARTON (60687-808-21)  / 1 TABLET in 1 BLISTER PACK (60687-808-11)",
          "marketing_start_date": "20240618",
          "sample": false
        }
      ],
      "listing_expiration_date": "20271231",
      "openfda": {},
      "marketing_category": "ANDA",
      "dosage_form": "TABLET",
      "spl_id": "5b8bf473-5fd1-7962-e063-6394a90a405f",
      "product_type": "HUMAN PRESCRIPTION DRUG",
      "route": [
        "ORAL"
      ],
      "marketing_start_date": "20240618",
      "product_id": "60687-808_5b8bf473-5fd1-7962-e063-6394a90a405f",
      "application_number": "ANDA206288",
      "brand_name_base": "Darunavir",
      "pharm_class": [
        "Cytochrome P450 2D6 Inhibitors [MoA]",
        "Cytochrome P450 3A Inhibitors [MoA]",
        "HIV Protease Inhibitors [MoA]",
        "Protease Inhibitor [EPC]"
      ]
    }
  ]
}